This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zumbansen, M. Articles by Stoffel, W. Search for Related Content PubMed PubMed Citation Articles by Zumbansen, M. Articles by Stoffel, W.

Neutral Sphingomyelinase 1 Deficiency in the Mouse Causes No Lipid Storage Disease

Laboratory of Molecular Neurosciences, Institute of Biochemistry, Faculty of Medicine, University of Cologne, Cologne, Germany

Received 26 November 2001/ Returned for modification 28 January 2002/ Accepted 26 February 2002

Sphingomyelin is a major lipid in the bilayer of subcellular membranes of eukaryotic cells. Different sphingomyelinases catalyze the initial step in the catabolism of sphingomyelin, the hydrolysis to phosphocholine and ceramide. Sphingomyelinases have been postulated to generate ceramide as a lipophilic second messenger in intracellular signaling pathways involved in cell proliferation, differentiation, or apoptosis. To elucidate the function of the first cloned Mg²⁺-dependent, neutral sphingomyelinase (nSMase 1) in sphingomyelin catabolism and its potential role in signaling processes in a genetic and molecular approach, we have generated an nSMase 1-null mutant mouse line by gene targeting. The nSMase 1-deficient mice show an unconspicuous phenotype and no accumulation or changed metabolism of sphingomyelin or other lipids, despite grossly reduced nSMase activity in all organs except brain. We also addressed the recent proposal that nSMase 1 possesses lysophospholipase C activity. The unaltered metabolism of lysophosphatidylcholine or lyso-platelet-activating factor excludes the proposed role of nSMase 1 as a lysophospholipase C.

This article has been cited by other articles:

• Corcoran, C. A., He, Q., Ponnusamy, S., Ogretmen, B., Huang, Y., Sheikh, M. S. (2008). Neutral Sphingomyelinase-3 Is a DNA Damage and Nongenotoxic Stress-Regulated Gene That Is Deregulated in Human Malignancies. Mol Cancer Res 6: 795-807 [Abstract] [Full Text]  
• Kim, W. J., Okimoto, R. A., Purton, L. E., Goodwin, M., Haserlat, S. M., Dayyani, F., Sweetser, D. A., McClatchey, A. I., Bernard, O. A., Look, A. T., Bell, D. W., Scadden, D. T., Haber, D. A. (2008). Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 111: 4716-4722 [Abstract] [Full Text]  
• Stoffel, W., Jenke, B., Holz, B., Binczek, E., Gunter, R. H., Knifka, J., Koebke, J., Niehoff, A. (2007). Neutral Sphingomyelinase (SMPD3) Deficiency Causes a Novel Form of Chondrodysplasia and Dwarfism That Is Rescued by Col2A1-Driven smpd3 Transgene Expression. Am. J. Pathol. 171: 153-161 [Abstract] [Full Text]  
• Tani, M., Hannun, Y. A. (2007). Neutral Sphingomyelinase 2 Is Palmitoylated on Multiple Cysteine Residues: ROLE OF PALMITOYLATION IN SUBCELLULAR LOCALIZATION. J. Biol. Chem. 282: 10047-10056 [Abstract] [Full Text]  
• Ng, C. G., Griffin, D. E. (2006). Acid Sphingomyelinase Deficiency Increases Susceptibility to Fatal Alphavirus Encephalomyelitis. J. Virol. 80: 10989-10999 [Abstract] [Full Text]  
• Krut, O., Wiegmann, K., Kashkar, H., Yazdanpanah, B., Kronke, M. (2006). Novel Tumor Necrosis Factor-responsive Mammalian Neutral Sphingomyelinase-3 Is a C-tail-anchored Protein. J. Biol. Chem. 281: 13784-13793 [Abstract] [Full Text]  
• Stoffel, W., Jenke, B., Block, B., Zumbansen, M., Koebke, J. (2005). Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc. Natl. Acad. Sci. USA 102: 4554-4559 [Abstract] [Full Text]  
• Marchesini, N., Luberto, C., Hannun, Y. A. (2003). Biochemical Properties of Mammalian Neutral Sphingomyelinase2 and Its Role in Sphingolipid Metabolism. J. Biol. Chem. 278: 13775-13783 [Abstract] [Full Text]